Search for: "Pharmaceutical Research and Manufacturers of America"
Results 41 - 60
of 410
Sort by Relevance
|
Sort by Date
14 Nov 2021, 6:40 am
Pharmaceutical Research and Manufacturers of America (PhRMA) PhRMA offers a Medicine Assistance Tool (MAT), which lets users search for healthcare financial assistance resources close to home. [read post]
6 Oct 2021, 2:01 pm
MNEs to invest in research and development (R&D) in the U.S. due to reduced after-tax income from intellectual property (IP) that has been located abroad. [read post]
12 Sep 2021, 3:58 am
The U.S. [read post]
7 Sep 2021, 1:47 pm
Wyden’s principles are largely compatible with the House proposal, which would use the threat of steep excise tax penalties of up to 1,900 percent of drug sales to make pharmaceutical manufacturers “agree” to lower their prices. [read post]
27 Aug 2021, 9:03 pm
Qi Andrew and Gucci America v. [read post]
25 Aug 2021, 10:59 am
” Due to declining revenues, pharmaceutical manufactures may reduce their spending on research and development (R&D). [read post]
17 Aug 2021, 6:08 am
The Pharmaceutical Research and Manufacturers of America (PhRMA) issued an updated August 2021 Code on Interaction with Health Care Professionals, which takes effect January 1, 2022. [read post]
16 Aug 2021, 2:01 pm
” Kohn points out that the Forbes article was written by “by the President of the Pacific Research Institute, a ‘think tank’ sponsored in part by numerous anti-whistleblower groups, and the recipient of over $300,000 from the primary representative of Big Pharma: the Pharmaceutical Research and Manufacturers of America. [read post]
13 Jul 2021, 10:58 am
., 2020) July 12, 2021 *We acknowledge the invaluable research assistance of Daniel Scarpitti, University of Toronto, Faculty of Law, 2L, in preparing these comments. [read post]
29 Jun 2021, 10:55 am
The Department of Commerce recommends these programs be fully funded to incentivize semiconductor manufacturing and research and development (R&D) to promote long-term U.S. leadership in the industry. [read post]
22 May 2021, 2:07 am
This case law deals with questions of claim construction and the scope of protection and affects the issue of the ‘skinny labelling’ by which a manufacturer tries to avoid infringement. [read post]
18 May 2021, 5:00 pm
The equipment industry consists of manufacturers of healthcare equipment and medical devices. [read post]
21 Apr 2021, 9:25 pm
By Donald Zuhn -- Last month, the Biotechnology Innovation Organization (BIO) and Pharmaceutical Research and Manufacturers of America (PhRMA) sent separate letters urging the Biden Administration to join the European Union, United Kingdom, Japan, Canada, Switzerland, Brazil, and Norway in opposing a proposal made by India and South Africa to have the World Trade Organization (WTO) waive the implementation, application and enforcement of certain provisions of the… [read post]
2 Apr 2021, 9:45 am
They now account for roughly 10% of our healthcare spending and America’s per capita outlay has nearly doubled over the past two decades. [read post]
22 Mar 2021, 9:01 pm
But, just as Ohio’s one-drug protocol began to spread, states encountered new difficulties in obtaining that drug.Bowing to pressure from abolitionist groups, many drug manufacturers decided to limit the distribution of sodium thiopental. [read post]
1 Mar 2021, 7:49 am
Aprecia Pharmaceuticals produced the first tablet manufactured through 3D printing to be approved by the FDA in 2015. [read post]
26 Jan 2021, 5:29 am
Key Findings Introduction Consumption Taxes in Brief Consumption Tax Revenues in OECD Countries Value-added Tax Sales Taxes Excise Taxes Excise Tax Trends Conclusion Appendix (See PDF) Key Findings Consumption taxes are a significant source of revenue for governments across the world, making up 32.3 percent of tax revenues in OECD countries in 2019. [read post]
6 Jan 2021, 5:01 am
The deal allows Chinese companies to participate in the growing market of European renewable energy and affords them more freedom in manufacturing. [read post]
11 Nov 2020, 4:14 pm
Delrahim made similar statements during his May 10, 2019 speech in Buenos Aires, Argentina, “Algo Esta Cambiando”: Innovation and Cooperation Among Antitrust Enforcers in the Americas, where he stated that, unlike in the past, the Antitrust Division may give credit to a company for having a “robust” corporate antitrust compliance program even if that program did not prevent an antitrust violation, although he did not specify what sort of credit may be given. [read post]
9 Oct 2020, 8:25 am
Stoll, Maintaining Post-Grant Review Estoppel in the America Invents Act: A Call for Legislative Restraint, 2012 Patently-O Patent Law Journal 1 (Stoll.2012.estoppel.pdf) Paul Morgan, The Ambiguity in Section 102(a)(1) of the Leahy-Smith America Invents Act, 2011 Patently-O Patent Law Journal 29. [read post]
